Why the study?
Does cardiac resynchronization therapy (CRT) improve clinical parameters and long-term survival in patients with end-stage heart failure?
Population
125 patients with end-stage heart failure, NYHA class III or IV, LVEF <35%, QRS duration >120 msec and left…
Design
Cohort
Follow-up
up to 3 years
Authors
Loading...
CRT response identifies better survival in end-stage HF; leaves open whether CRT confers causal benefit versus medical therapy alone.
Does cardiac resynchronization therapy (CRT) improve clinical parameters and long-term survival in patients with end-stage heart failure?
CRT provides sustained long-term clinical improvement and reduced hospitalization in end-stage heart failure, with initial clinical responders demonstrating significantly better long-term survival.
Molhoek et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: